KRAS and intrahepatic cholangiocarcinoma: A combination of other non-PIK3CA mutations including FBXW7, KRAS, PTEN, ERBB3, TP53, ERBB2, EP300 and MAPK1 were also associated with precancer and ICC, but only when classified as TIER1.